LFST
LifeStance Health Group, Inc.
Price Chart
Latest Quote
$9.86
| Previous Close | $9.65 |
| Open | $9.61 |
| Day High | $9.97 |
| Day Low | $9.57 |
| Volume | 1,142,383 |
Stock Information
| Shares Outstanding | 381.83M |
| Total Debt | $476.77M |
| Cash Equivalents | $194.80M |
| Revenue | $1.49B |
| Net Income | $23.20M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $3.76B |
| P/E Ratio | 164.25 |
| EPS (TTM) | $0.06 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.02B |
| Sales | $1.49B |
| Income | $23.20M |
| Book/sh | $3.81 |
| Cash/sh | $0.51 |
| Employees | 8K |
Financial Ratios
| Quick Ratio | 1.32 |
| Current Ratio | 1.49 |
| Debt/Eq | 32.27 |
| EPS Growth TTM | 1908.90% |
Returns & Margins
| ROA | 1.35% |
| ROE | 1.58% |
| Gross Margin | 32.60% |
| Operating Margin | 5.54% |
| Profit Margin | 1.55% |
Ownership
| Insider Ownership | 4.54% |
| Institutional Ownership | 88.62% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 25.14 |
| P/S | 2.52 |
| P/B | 2.59 |
Analyst Data
| Recommendation | buy |
| Target Price | $10.55 |
Technical Indicators
| SMA20 | $8.33 |
| SMA50 | $7.80 |
| SMA200 | $6.72 |
| RSI | 86.25 |
| ATR | 0.3417 |
| Shares Float | 237.99M |
| Short Float | 4.31% |
| Short Ratio | 1.10 |
| Volatility | 1.19 |
| Rel Volume | 0.41 |
Performance History
| Week | +14.46% |
| Month | +30.18% |
| Quarter | +48.20% |
| 6 Months | +39.79% |
| YTD | +41.59% |
| Year | +94.00% |
| 3 Years | +6.89% |
| 5 Years | -62.10% |
| 10 Years | -55.00% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $9.85 | 1,142,383 |
| 2026-06-24 | $9.65 | 3,438,300 |
| 2026-06-23 | $9.44 | 2,933,500 |
| 2026-06-22 | $9.20 | 4,840,900 |
| 2026-06-18 | $8.98 | 6,914,900 |
| 2026-06-17 | $8.61 | 2,688,800 |
| 2026-06-16 | $8.62 | 2,274,500 |
| 2026-06-15 | $8.59 | 2,225,800 |
| 2026-06-12 | $8.50 | 2,788,300 |
| 2026-06-11 | $8.61 | 6,073,100 |
| 2026-06-10 | $7.86 | 2,129,900 |
| 2026-06-09 | $7.66 | 1,936,400 |
| 2026-06-08 | $7.34 | 2,109,600 |
| 2026-06-05 | $7.41 | 1,924,000 |
| 2026-06-04 | $7.64 | 1,652,100 |
| 2026-06-03 | $7.50 | 1,962,300 |
| 2026-06-02 | $7.76 | 2,152,900 |
| 2026-06-01 | $7.94 | 2,221,700 |
| 2026-05-29 | $7.71 | 2,588,900 |
| 2026-05-28 | $7.81 | 2,219,200 |
| 2026-05-27 | $7.61 | 3,068,500 |
| 2026-05-26 | $7.57 | 2,923,400 |
About LifeStance Health Group, Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
đ° Latest News
1 Russell 2000 Stock for Long-Term Investors and 2 We Ignore
StockStory âĸ 2026-06-24T09:04:25Z2 Profitable Stocks Worth Investigating and 1 Facing Challenges
StockStory âĸ 2026-06-22T07:31:19ZLifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know
Zacks âĸ 2026-06-18T16:00:03ZZacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare
Zacks âĸ 2026-06-10T13:22:00Z4 Outpatient Home Health Stocks Benefiting From Industry Trends
Zacks âĸ 2026-06-09T14:40:00ZAssessing LifeStance Health Group (LFST) Valuation After Recent Share Price Momentum
Simply Wall St. âĸ 2026-06-01T22:08:19Z1 Healthcare Stock with Promising Prospects and 2 We Find Risky
StockStory âĸ 2026-06-01T12:08:51ZWall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know
Zacks âĸ 2026-05-29T13:55:02ZBears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now
Zacks âĸ 2026-05-26T13:55:02Z1 Growth Stock to Add to Your Roster and 2 We Turn Down
StockStory âĸ 2026-05-25T13:07:51ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $963,186,000 | $848,571,000 | $753,569,000 | $622,525,000 |
| Cost Of Revenue | $963,186,000 | $848,571,000 | $753,569,000 | $622,525,000 |
| Total Revenue | $1,424,285,000 | $1,250,970,000 | $1,055,665,000 | $859,542,000 |
| Operating Revenue | $1,424,285,000 | $1,250,970,000 | $1,055,665,000 | $859,542,000 |
| Expenses | ||||
| Interest Expense | $11,662,000 | $26,535,000 | $21,220,000 | $19,928,000 |
| Total Expenses | $1,400,137,000 | $1,282,583,000 | $1,244,799,000 | $1,069,716,000 |
| Other Income Expense | $-123,000 | $535,000 | $3,771,000 | $-2,628,000 |
| Other Non Operating Income Expenses | $-123,000 | $-363,000 | $-112,000 | $-218,000 |
| Net Non Operating Interest Income Expense | $-11,662,000 | $-26,535,000 | $-21,220,000 | $-19,928,000 |
| Interest Expense Non Operating | $11,662,000 | $26,535,000 | $21,220,000 | $19,928,000 |
| Operating Expense | $436,951,000 | $434,012,000 | $491,230,000 | $447,191,000 |
| General And Administrative Expense | $382,198,000 | $363,062,000 | $410,793,000 | $377,993,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $9,663,000 | $-57,443,000 | $-186,262,000 | $-215,564,000 |
| Net Interest Income | $-11,662,000 | $-26,535,000 | $-21,220,000 | $-19,928,000 |
| Normalized Income | $9,663,000 | $-58,338,306 | $-189,764,466 | $-213,332,340 |
| Net Income From Continuing And Discontinued Operation | $9,663,000 | $-57,443,000 | $-186,262,000 | $-215,564,000 |
| Total Operating Income As Reported | $24,148,000 | $-31,613,000 | $-189,134,000 | $-210,174,000 |
| Net Income Common Stockholders | $9,663,000 | $-57,443,000 | $-186,262,000 | $-215,564,000 |
| Net Income | $9,663,000 | $-57,443,000 | $-186,262,000 | $-215,564,000 |
| Net Income Including Noncontrolling Interests | $9,663,000 | $-57,443,000 | $-186,262,000 | $-215,564,000 |
| Net Income Continuous Operations | $9,663,000 | $-57,443,000 | $-186,262,000 | $-215,564,000 |
| Pretax Income | $12,363,000 | $-57,613,000 | $-206,583,000 | $-232,730,000 |
| Special Income Charges | $0 | $898,000 | $3,883,000 | $-2,410,000 |
| Operating Income | $24,148,000 | $-31,613,000 | $-189,134,000 | $-210,174,000 |
| Depreciation Amortization Depletion Income Statement | $54,753,000 | $70,950,000 | $80,437,000 | $69,198,000 |
| Depreciation And Amortization In Income Statement | $54,753,000 | $70,950,000 | $80,437,000 | $69,198,000 |
| Gross Profit | $461,099,000 | $402,399,000 | $302,096,000 | $237,017,000 |
| Per Share | ||||
| Diluted EPS | $0.02 | $-0.15 | $-0.51 | $-0.61 |
| Basic EPS | $0.03 | $-0.15 | $-0.51 | $-0.61 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $2,694 | $380,534 | $-178,340 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $78,778,000 | $38,974,000 | $-108,809,000 | $-141,194,000 |
| Total Unusual Items | $0 | $898,000 | $3,883,000 | $-2,410,000 |
| Total Unusual Items Excluding Goodwill | $0 | $898,000 | $3,883,000 | $-2,410,000 |
| Reconciled Depreciation | $54,753,000 | $70,950,000 | $80,437,000 | $69,198,000 |
| EBITDA (Bullshit earnings) | $78,778,000 | $39,872,000 | $-104,926,000 | $-143,604,000 |
| EBIT | $24,025,000 | $-31,078,000 | $-185,363,000 | $-212,802,000 |
| Diluted Average Shares | $391,136,000 | $379,147,000 | $367,457,000 | $355,278,000 |
| Basic Average Shares | $386,016,000 | $379,147,000 | $367,457,000 | $355,278,000 |
| Diluted NI Availto Com Stockholders | $9,663,000 | $-57,443,000 | $-186,262,000 | $-215,564,000 |
| Tax Provision | $2,700,000 | $-170,000 | $-20,321,000 | $-17,166,000 |
| Restructuring And Mergern Acquisition | $0 | $-898,000 | $-3,883,000 | $2,410,000 |
| Selling General And Administration | $382,198,000 | $363,062,000 | $410,793,000 | $377,993,000 |
| Other Gand A | $382,198,000 | $363,062,000 | $410,793,000 | $377,993,000 |
| Otherunder Preferred Stock Dividend | - | - | $0 | $0 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $50,004,000 | $-37,860,000 | $-85,488,000 | $-17,510,000 |
| Total Assets | $2,203,933,000 | $2,118,298,000 | $2,109,969,000 | $2,173,871,000 |
| Total Non Current Assets | $1,787,733,000 | $1,805,788,000 | $1,884,238,000 | $1,940,648,000 |
| Other Non Current Assets | $5,419,000 | $7,724,000 | $10,895,000 | $10,795,000 |
| Goodwill And Other Intangible Assets | $1,471,011,000 | $1,484,145,000 | $1,514,418,000 | $1,536,233,000 |
| Other Intangible Assets | $177,665,000 | $190,799,000 | $221,072,000 | $263,294,000 |
| Current Assets | $416,200,000 | $312,510,000 | $225,731,000 | $233,223,000 |
| Other Current Assets | $19,928,000 | $14,903,000 | $10,729,000 | $10,997,000 |
| Prepaid Assets | $48,130,000 | $11,011,000 | $10,538,000 | $12,097,000 |
| Receivables | $99,500,000 | $132,025,000 | $125,640,000 | $101,508,000 |
| Other Receivables | $3,790,000 | $223,000 | $235,000 | $640,000 |
| Accounts Receivable | $95,710,000 | $131,802,000 | $125,405,000 | $100,868,000 |
| Cash Cash Equivalents And Short Term Investments | $248,642,000 | $154,571,000 | $78,824,000 | $108,621,000 |
| Cash And Cash Equivalents | $248,642,000 | $154,571,000 | $78,824,000 | $108,621,000 |
| Non Current Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $31,785,000 | $132,469,000 | $204,386,000 | $116,458,000 |
| Total Debt | $474,524,000 | $485,188,000 | $511,042,000 | $476,489,000 |
| Long Term Debt And Capital Lease Obligation | $414,480,000 | $428,489,000 | $461,642,000 | $437,665,000 |
| Long Term Debt | $265,927,000 | $279,790,000 | $280,285,000 | $225,079,000 |
| Current Debt And Capital Lease Obligation | $60,044,000 | $56,699,000 | $49,400,000 | $38,824,000 |
| Current Debt | $14,500,000 | $7,250,000 | $2,925,000 | $2,345,000 |
| Other Current Borrowings | $14,500,000 | $7,250,000 | $2,925,000 | $2,345,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $682,918,000 | $672,013,000 | $681,039,000 | $655,148,000 |
| Total Non Current Liabilities Net Minority Interest | $430,956,000 | $443,127,000 | $478,166,000 | $479,149,000 |
| Other Non Current Liabilities | $68,000 | $309,000 | $952,000 | $2,783,000 |
| Non Current Deferred Liabilities | $16,408,000 | $14,329,000 | $15,572,000 | $38,701,000 |
| Non Current Deferred Taxes Liabilities | $16,408,000 | $14,329,000 | $15,572,000 | $38,701,000 |
| Current Liabilities | $251,962,000 | $228,886,000 | $202,873,000 | $175,999,000 |
| Other Current Liabilities | $282,000 | $542,000 | $8,932,000 | $18,812,000 |
| Payables And Accrued Expenses | $191,636,000 | $171,645,000 | $144,541,000 | $118,363,000 |
| Payables | $18,854,000 | $25,675,000 | $23,209,000 | $24,370,000 |
| Accounts Payable | $18,854,000 | $25,675,000 | $23,209,000 | $24,370,000 |
| Other Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $1,521,015,000 | $1,446,285,000 | $1,428,930,000 | $1,518,723,000 |
| Total Equity Gross Minority Interest | $1,521,015,000 | $1,446,285,000 | $1,428,930,000 | $1,518,723,000 |
| Stockholders Equity | $1,521,015,000 | $1,446,285,000 | $1,428,930,000 | $1,518,723,000 |
| Gains Losses Not Affecting Retained Earnings | $0 | $929,000 | $2,303,000 | $3,274,000 |
| Retained Earnings | $-808,626,000 | $-818,289,000 | $-760,846,000 | $-572,636,000 |
| Other Equity Adjustments | - | $929,000 | $2,303,000 | $3,274,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $388,318,000 | $382,735,000 | $378,725,000 | $375,964,000 |
| Share Issued | $388,318,000 | $382,735,000 | $378,725,000 | $375,964,000 |
| Tangible Book Value | $50,004,000 | $-37,860,000 | $-85,488,000 | $-17,510,000 |
| Invested Capital | $1,801,442,000 | $1,733,325,000 | $1,712,140,000 | $1,743,802,000 |
| Working Capital | $164,238,000 | $83,624,000 | $22,858,000 | $57,224,000 |
| Capital Lease Obligations | $194,097,000 | $198,148,000 | $227,832,000 | $251,410,000 |
| Total Capitalization | $1,786,942,000 | $1,726,075,000 | $1,709,215,000 | $1,743,802,000 |
| Additional Paid In Capital | $2,325,758,000 | $2,259,818,000 | $2,183,684,000 | $2,084,324,000 |
| Capital Stock | $3,883,000 | $3,827,000 | $3,789,000 | $3,761,000 |
| Common Stock | $3,883,000 | $3,827,000 | $3,789,000 | $3,761,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $148,553,000 | $148,699,000 | $181,357,000 | $212,586,000 |
| Current Capital Lease Obligation | $45,544,000 | $49,449,000 | $46,475,000 | $38,824,000 |
| Current Accrued Expenses | $172,782,000 | $145,970,000 | $121,332,000 | $93,993,000 |
| Goodwill | $1,293,346,000 | $1,293,346,000 | $1,293,346,000 | $1,272,939,000 |
| Net PPE | $311,303,000 | $313,919,000 | $358,925,000 | $393,620,000 |
| Accumulated Depreciation | $-132,074,000 | $-101,873,000 | $-68,684,000 | $-42,883,000 |
| Gross PPE | $443,377,000 | $415,792,000 | $427,609,000 | $436,503,000 |
| Leases | $194,653,000 | $178,407,000 | $170,212,000 | $148,249,000 |
| Construction In Progress | $13,380,000 | $7,874,000 | $9,037,000 | $16,892,000 |
| Other Properties | $150,793,000 | $148,720,000 | $171,545,000 | $200,381,000 |
| Machinery Furniture Equipment | $84,551,000 | $80,791,000 | $76,815,000 | $70,981,000 |
| Properties | $0 | $0 | $0 | $0 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $110,026,000 | $85,694,000 | $-57,404,000 | $-26,466,000 |
| Operating Activities | ||||
| Operating Cash Flow | $146,151,000 | $107,260,000 | $-16,884,000 | $52,789,000 |
| Cash Flow From Continuing Operating Activities | $146,151,000 | $107,260,000 | $-16,884,000 | $52,789,000 |
| Operating Gains Losses | - | $5,032,000 | - | $3,380,000 |
| Investing Activities | ||||
| Capital Expenditure | $-36,125,000 | $-21,566,000 | $-40,520,000 | $-79,255,000 |
| Investing Cash Flow | $-36,125,000 | $-21,566,000 | $-60,340,000 | $-139,461,000 |
| Cash Flow From Continuing Investing Activities | $-36,125,000 | $-21,566,000 | $-60,340,000 | $-139,461,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-15,955,000 | $-9,947,000 | $47,427,000 | $47,264,000 |
| Cash Flow From Continuing Financing Activities | $-15,955,000 | $-9,947,000 | $47,427,000 | $47,264,000 |
| Net Other Financing Charges | $-8,705,000 | $-8,262,000 | $-7,856,000 | $-22,294,000 |
| Issuance Of Capital Stock | - | - | $0 | $0 |
| Net Common Stock Issuance | - | - | $0 | $0 |
| Common Stock Issuance | - | - | $0 | $0 |
| Repurchase Of Capital Stock | - | - | - | $0 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-7,250,000 | $-289,494,000 | $-2,470,000 | $-187,766,000 |
| Issuance Of Debt | $0 | $287,809,000 | $57,753,000 | $257,324,000 |
| Interest Paid Supplemental Data | $17,800,000 | $24,992,000 | $21,044,000 | $14,365,000 |
| Income Tax Paid Supplemental Data | $1,574,000 | $57,000 | $80,000 | $2,237,000 |
| End Cash Position | $248,642,000 | $154,571,000 | $78,824,000 | $108,621,000 |
| Beginning Cash Position | $154,571,000 | $78,824,000 | $108,621,000 | $148,029,000 |
| Changes In Cash | $94,071,000 | $75,747,000 | $-29,797,000 | $-39,408,000 |
| Net Issuance Payments Of Debt | $-7,250,000 | $-1,685,000 | $55,283,000 | $69,558,000 |
| Net Long Term Debt Issuance | $-7,250,000 | $-1,685,000 | $55,283,000 | $69,558,000 |
| Long Term Debt Payments | $-7,250,000 | $-289,494,000 | $-2,470,000 | $-187,766,000 |
| Long Term Debt Issuance | $0 | $287,809,000 | $57,753,000 | $257,324,000 |
| Net Business Purchase And Sale | $0 | $0 | $-19,820,000 | $-60,206,000 |
| Purchase Of Business | $0 | $0 | $-19,820,000 | $-60,206,000 |
| Net PPE Purchase And Sale | $-36,125,000 | $-21,566,000 | $-40,520,000 | $-79,255,000 |
| Purchase Of PPE | $-36,125,000 | $-21,566,000 | $-40,520,000 | $-79,255,000 |
| Change In Working Capital | $-40,344,000 | $-27,367,000 | $-33,723,000 | $-16,938,000 |
| Change In Other Current Liabilities | $-48,129,000 | $-46,748,000 | $-37,564,000 | $-13,169,000 |
| Change In Payables And Accrued Expense | $18,378,000 | $29,110,000 | $31,086,000 | $21,325,000 |
| Change In Accrued Expense | $19,941,000 | $28,609,000 | $36,691,000 | $13,658,000 |
| Change In Payable | $-1,563,000 | $501,000 | $-5,605,000 | $7,667,000 |
| Change In Account Payable | $-1,563,000 | $501,000 | $-5,605,000 | $7,667,000 |
| Change In Prepaid Assets | $-46,685,000 | $-3,332,000 | $-3,070,000 | $-3,431,000 |
| Change In Receivables | $36,092,000 | $-6,397,000 | $-24,175,000 | $-21,663,000 |
| Changes In Account Receivables | $36,092,000 | $-6,397,000 | $-24,175,000 | $-21,663,000 |
| Other Non Cash Items | $44,956,000 | $40,874,000 | $45,196,000 | $42,016,000 |
| Stock Based Compensation | $74,701,000 | $76,172,000 | $99,388,000 | $187,430,000 |
| Deferred Tax | $2,422,000 | $-958,000 | $-21,920,000 | $-16,733,000 |
| Deferred Income Tax | $2,422,000 | $-958,000 | $-21,920,000 | $-16,733,000 |
| Depreciation Amortization Depletion | $54,753,000 | $70,950,000 | $80,437,000 | $69,198,000 |
| Depreciation And Amortization | $54,753,000 | $70,950,000 | $80,437,000 | $69,198,000 |
| Amortization Cash Flow | $13,134,000 | $30,273,000 | $43,065,000 | $40,280,000 |
| Amortization Of Intangibles | $13,134,000 | $30,273,000 | $43,065,000 | $40,280,000 |
| Depreciation | $41,619,000 | $40,677,000 | $37,372,000 | $28,918,000 |
| Net Income From Continuing Operations | $9,663,000 | $-57,443,000 | $-186,262,000 | $-215,564,000 |
| Preferred Stock Payments | - | - | - | $0 |